Hedge Funds Similar to Aisling

13F Portfolio OverlapQ1 2026Aisling portfolio →
Institutional-grade research for retail investors

Most similar hedge funds by 13F overlap

Aisling Capital Management LP is an institutional investor managing $476M across 13 U.S. equity positions as of Q1 2026. Based on the overlap of conviction holdings in their latest 13F filings, the hedge funds with portfolios most similar to Aisling are SILVERARC ,, Frazier Life Sciences ,, Eagle Health Investments, with shared positions in $GLUE, $SNDX, $SRRK, $URGN, $BBIO, $ACRS. The full ranking of 18 similar funds is below.

Some overlap · 4 shared positions
$980M
73 positions
Some overlap · 3 shared positions
$3.9B
38 positions
Some overlap · 3 shared positions
$572M
28 positions
Some overlap · 3 shared positions
$1.8B
26 positions
Some overlap · 3 shared positions
$2.0B
47 positions
Some overlap · 3 shared positions
$654M
51 positions
Some overlap · 3 shared positions
$3.6B
90 positions
Some overlap · 3 shared positions
$440M
83 positions
Some overlap · 4 shared positions
$1.3B
41 positions
Some overlap · 3 shared positions
$6.1B
63 positions
Some overlap · 3 shared positions
$911M
62 positions
Slight overlap · 3 shared positions
$352M
22 positions
Slight overlap · 3 shared positions
$124M
27 positions
Slight overlap · 3 shared positions
$141M
79 positions
Slight overlap · 3 shared positions
$4.9B
35 positions
#16Casdin Capital, LLCSmart money
Slight overlap · 3 shared positions
$1.3B
40 positions
Slight overlap · 3 shared positions
$140M
35 positions
Slight overlap · 3 shared positions
$1.2B
45 positions

Compare Aisling’s portfolio side by side

See the exact shared positions, conviction overlap, sector alignment, and where these funds diverge — and run the same analysis on any of 8,700+ institutions.

View Aisling’s holdings

Similarity is derived from each fund’s latest 13F-HR filing with the SEC. Funds are ranked by the overlap of distinctive conviction holdings; near-universal mega-cap positions are excluded so the ranking reflects shared strategy, not common index exposure. Data is informational only and not investment advice.